Investors need to think about this!
There are 2 Andrews agreements. 1 is a license agreement and the other is a consulting agreement. Nowhere is it stated the funding required or committed for the balance of the IND. Where does the money come from for the inVentiv engagement? For the IND work?
Additionally, the Andrews consulting agreement has escalators based off of 15 and 25 million capital raise. YA came in with the minimum 2 mil to kickstart the agreement.
I believe it is reasonable to believe that there is a large entity waiting in the wings to partner and fund this IND. Everything seems structured for that. Andrews is calling this potentially a game changer, we know the cost effectiveness, low risk, ease of process and cell mix are HUGE advantages. This can be THE gold standard for oestarthritis treatments and certainly worth a minor partnership or investment from entities with significant capacity to finance and exploit. Insurance companies will salivate over this treatment versus expensive therapy and pain management drugs that are just a band aid permanently.
So, this can channel in a range for weeks and months but if news as speculated surfaces, you will blink and this will multiply and multiply. Seen it before, major news and 500-1000% 2 day run. And that is just the beginning or in some cases a rebirth.
GLTA. ;)
